Chemotherapy Hair Loss MDL Will Be Considered At Sept. 29 Hearing
(August 12, 2016, 1:31 PM EDT) -- WASHINGTON, D.C. — Arguments will be heard Sept. 29 on the centralization of federal lawsuits in which breast cancer patients allege that the chemotherapy drug Taxotere causes permanent hair loss, according...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login